The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients

Author:

McAleavy Megan1,Zhang Qian1,Ehmann Peter J.1,Xu Jianing1,Wipperman Matthew F.1,Ajithdoss Dharani1,Pan Li1,Wakai Matthew1,Simonson Raphael1,Gadi Abhilash1,Oyejide Adelekan1,Hamon Sara C.1,Boyapati Anita1,Morton Lori G.1,Shavlakadze Tea1,Kyratsous Christos A.1,Glass David J.1ORCID

Affiliation:

1. Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA

Abstract

A subset of hospitalized COVID-19 patients, particularly the aged and those with comorbidities, develop the most severe form of the disease, characterized by Acute Respiratory Disease Syndrome (ARDS), coincident with experiencing a “cytokine storm.” Here, we demonstrate that cytokines which activate the NF-κB pathway can induce activin A. Patients with elevated activin A, activin B, and FLRG at hospital admission were associated with the most severe outcomes of COVID-19, including the requirement for mechanical ventilation, and all-cause mortality.

Funder

Regeneron Pharmaceuticals

Publisher

American Society for Microbiology

Subject

Cell Biology,Molecular Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3